James E. Flynn, Ten Percent Owner Other at XERIS PHARMACEUTICALS INC (XERS), sold 228,888 shares at $15.03 ($3.5M) on 2019-01-24, disclosed to the SEC on 2019-01-25.
Open-market sale of $3.5M XERS by Ten Percent Owner Other. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.35 | 32,199 | $526K | 14.9% |
| 2 | $16.35 | 32,199 | $526K | 14.9% |
| 3 | $15.03 | 5,425 | $82K | 2.3% |
| 4 | $15.03 | 5,425 | $82K | 2.3% |
| 5 | $15.08 | 76,820 | $1.2M | 32.8% |
| 6 | $15.08 | 76,820 |
| $1.2M |
| 32.8% |
| Total | $15.43 avg | 228,888 | $3.5M | 100% |
| Filing → |
| SPRY | SELL | 2025-07-01 | $27.3M | — | Filing → |
| ONCR | SELL | 2022-12-30 | $65K | — | Filing → |
| ONCR | SELL | 2022-12-21 | $23K | — | Filing → |